Skip to content
  • Sunday, 26 July 2026
  • 2:58 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Sai Life Sciences Plans to Recruit 700+ Professionals in FY27 as Indian CRDMO Demand Accelerates
Laboratory Automation & Robotics

Sai Life Sciences Plans to Recruit 700+ Professionals in FY27 as Indian CRDMO Demand Accelerates

Lana Keisha Apr 14, 2026 0

Hyderabad, India – Sai Life Sciences, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has announced an ambitious…

Read More
Laboratory Automation & Robotics

Sai Life Sciences Plans to Recruit 700+ Professionals in FY27 as Indian CRDMO Demand Accelerates

Lana Keisha Apr 3, 2026 0

Sai Life Sciences, a leading Contract Research, Development, and Manufacturing Organization (CRDMO) based in Hyderabad, India, has announced an ambitious…

Read More
Laboratory Automation & Robotics

Sai Life Sciences plans to recruit 700+ professionals in FY27 as Indian CRDMO demand accelerates

Lana Keisha Mar 26, 2026 0

Hyderabad-based Sai Life Sciences, a leading Contract Research, Development, and Manufacturing Organization (CRDMO), has announced ambitious plans to hire more…

Read More
Laboratory Automation & Robotics

Sai Life Sciences plans to recruit 700+ professionals in FY27 as Indian CRDMO demand accelerates

Lana Keisha Mar 19, 2026 0

Sai Life Sciences, a prominent Contract Research, Development & Manufacturing Organization (CRDMO) based in Hyderabad, India, has announced an ambitious…

Read More
Canadian Researchers Identify Potential HIV Drug Repurposing to Combat Aggressive Glioblastoma Brain TumorsThe Key to Keeping Mangoes Fresh: Hainan University Researchers Uncover Optimal Storage Temperature to Combat SpoilageSea Cucumber Tentacles Can Survive Independently After DetachmentInflammatory Remodeling of the Bone Marrow Niche: New Insights into the Early Drivers of Clonal Hematopoiesis and Myelodysplastic Syndrome
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ